PCSK9 inhibitors: The breakthrough lipid-lowering treatment at real-life setting – A 2-year regional lipid clinic experience Georgia Anastasiou, George Liamis, Haralampos Milionis, Moses Elisaf, Eliza Christopoulou, Theodora Dimitriou, Evangelos N. Liberopoulos
The role of lipid-lowering treatment in the secondary prevention of ischemic stroke Eirini Konstantinidou, Konstantinos Tziomalos
Europe to US: Re-establish specific low density lipoprotein cholesterol targets because we all need them Vasilios G. Athyros, Konstantinos Tziomalos, Asterios Karagiannis